Indefinite Delivery Contract SPE2DX15D9258

This is an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,999,999, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

The task orders under this IDC cover a diverse portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, including specialized medications such as Xolair, Trikafta, Keytruda, Botox, and Nucala. The contract allows DMS Pharmaceutical Group to directly distribute these pharmaceutical items and provide pharmacy services to Department of Defense healthcare sites, positioning the company as a critical supplier in the federal pharmaceutical supply chain. The IDC has an ultimate completion date of December 31, 2025 and does not utilize any set-aside designations, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure these federal contract awards.